Stock Traders Purchase High Volume of GE HealthCare Technologies Call Options (NASDAQ:GEHC)

GE HealthCare Technologies Inc. (NASDAQ:GEHC) was the recipient of some unusual options trading activity on Wednesday. Stock traders bought 8,956 call options on the company. This represents an increase of 45% compared to the average volume of 6,169 call options.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of research analyst reports. Citigroup increased their price target on GE HealthCare Technologies from $69.00 to $75.00 and gave the stock a “neutral” rating in a research report on Thursday. Rothschild & Co Redburn cut their price objective on GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. Barclays reduced their price objective on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 30th. Jefferies Financial Group decreased their target price on GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. Finally, Argus lowered their target price on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Tuesday, May 19th. Ten equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Hold” and an average target price of $77.45.

Key Headlines Impacting GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Strong second-quarter results: GE HealthCare reported adjusted earnings of $1.13 per share versus the $1.04 consensus estimate, while revenue reached approximately $5.3 billion, ahead of expectations and up roughly 5.8% year over year. GE HealthCare reports second quarter 2026 financial results
• Positive Sentiment: Orders and backlog reached records: Organic orders increased about 11%, and total backlog rose to $23.9 billion. Strong demand for imaging, diagnostics and healthcare infrastructure gives GEHC greater revenue visibility. GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refunds
• Positive Sentiment: Management outlook and analyst sentiment improved: Reports indicate GEHC raised its EPS guidance, while Wells Fargo lifted its price target from $75 to $85 with an overweight rating. BTIG also raised its target to $79 and maintained a buy rating. GE HealthCare raises EPS guidance and reports record backlog
• Neutral Sentiment: Trading activity intensified: GEHC experienced unusually high options volume, including increased call buying. This may reflect bullish positioning, but options activity can also increase short-term volatility rather than signal a lasting change in valuation. GE HealthCare Technologies sees unusually high options volume
• Negative Sentiment: Profit quality and margins remain concerns: A tariff refund and lower tax rate contributed to the earnings beat, while adjusted EBIT margin contracted. Patient Care Solutions revenue declined sharply and the unit posted negative EBIT; management is reviewing strategic alternatives, including a possible sale.
• Negative Sentiment: Securities-fraud investigations added headline risk: Several law firms announced investigations into possible federal securities-law violations and solicited affected investors. These announcements do not establish wrongdoing, but they can pressure sentiment and create potential legal costs or liability. Securities fraud investigation into GE HealthCare continues

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $69.94 on Friday. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.26 and a quick ratio of 0.95. The firm has a market cap of $31.82 billion, a P/E ratio of 16.04, a P/E/G ratio of 1.96 and a beta of 0.72. The firm has a 50 day simple moving average of $63.94 and a 200 day simple moving average of $70.57. GE HealthCare Technologies has a fifty-two week low of $58.75 and a fifty-two week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm had revenue of $5.29 billion during the quarter, compared to analysts’ expectations of $5.26 billion. During the same quarter in the previous year, the company posted $1.06 EPS. GE HealthCare Technologies’s revenue was up 5.8% on a year-over-year basis. Sell-side analysts predict that GE HealthCare Technologies will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.35%.

Insiders Place Their Bets

In other news, Director Rodney F. Hochman acquired 1,618 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were purchased at an average cost of $62.03 per share, with a total value of $100,364.54. Following the completion of the purchase, the director owned 1,618 shares of the company’s stock, valued at $100,364.54. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kevin Lobo acquired 10,000 shares of the company’s stock in a transaction dated Friday, May 22nd. The shares were purchased at an average cost of $64.18 per share, with a total value of $641,800.00. Following the acquisition, the director owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This represents a 229.20% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders have bought 12,618 shares of company stock valued at $805,175. 0.36% of the stock is currently owned by insiders.

Hedge Funds Weigh In On GE HealthCare Technologies

Several large investors have recently made changes to their positions in the company. Laurel Wealth Advisors LLC bought a new stake in GE HealthCare Technologies during the 4th quarter worth about $26,000. Optima Capital LLC acquired a new position in GE HealthCare Technologies during the 4th quarter valued at about $27,000. Godfrey Financial Associates Inc. bought a new position in shares of GE HealthCare Technologies in the 4th quarter valued at about $27,000. Montag A & Associates Inc. boosted its stake in shares of GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC grew its position in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after buying an additional 262 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.